Cell Res.2021 Sep 24.doi: 10.1038/s41422-021-00565-y. Nuclear UHRF1 is a gate-keeper of cellular AMPK activity and function (IF:25.617).
Acta Pharm Sin B.2021 Sep;11(9):2880-2899.doi: 10.1016/j.apsb.2021.03.011.Epub 2021 Mar 9.Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation.溃疡性结肠炎(IF:11.413).
Mol Ther Nucleic Acids.2021 Mar 16;24:352-368.doi: 10.1016/j.omtn.2021.03.004.eCollection 2021 Jun 4.Circular RNA circMYBPC1 promotes skeletal muscle differentiation by targeting MyHC.环状RNA circMYBPC1通过靶向MyHC促进骨骼肌分化(IF:8.886).
Theranostics.2021 Jan 1;11(2):893-905.doi: 10.7150/thno.48080. eCollection 2021.uman umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis人脐带间干细胞治疗通过MiR-199a-5p/Sirt1/p53轴促进CD4+T细胞衰老改善狼疮(IF:11.556).
Mol Ther.2020 Nov 4;28(11):2442-2457.doi: 10.1016/j.ymthe.2020.09.010.Epub 2020 Sep 6.Lactate Induces Production of the tRNA His Half to Promote B-lymphoblastic Cell Proliferation.乳酸诱导tRNA His半体的产生,促进B淋巴细胞增殖.(IF:11.454).
Br J Pharmacol.2020 Aug;177(16):3760-3777.doi: 10.1111/bph.15099. Epub 2020 Jun 27.Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non-alcoholic fatty liver disease by up-regulating the FGF21/PGC-1α pathway.葡萄黄质通过上调FGF21/PGC-1α途径减轻非酒精性脂肪肝的肝损伤和线粒体功能障碍(IF:8.739).
Theranostics.2020 Aug 29;10(24):10908-10924.doi: 10.7150/thno.48264. eCollection 2020.Circular RNA circPPM1F modulates M1 macrophage activation and pancreatic islet inflammation in type 1 diabetes mellitus. 环状RNAcircPPM1F调节M1巨噬细胞的活化和胰岛炎症(IF:11.556).
Small.2020 Jul;16(30):e1907301.doi: 10.1002/smll.201907301. Epub 2020 Jun 25.Photoactivatable RNA N 6 -Methyladenosine Editing with CRISPR-Cas13甲基腺苷编辑(IF:13.281).
Nat Commun. 2019 Sep 20;10(1):4303.doi: 10.1038/s41467-019-12351-x. (IF:12.121).
Inactivation of NF-κB2 (p52) restrains hepatic glucagon response via preserving PDE4B induction.（肝胰高血糖素反应研究）
J Immunother Cancer. 2019 Aug 7;7(1):209. doi: 10.1186/s40425-019-0685-y.(IF:8.676). PD-1 silencing impairs the anti-tumor function of chimeric antigen receptor modified T cells by inhibiting proliferation activity.（PD-1与嵌合抗原受体修饰T细胞的抗肿瘤作用研究）
